# A Study to Assess Efficacy and Safety of N-Acetyl-GED-0507-34-LEVO Gel 5% in Patients With Acne Vulgaris (GEDACNE 2)

> **NCT07384208** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **PPM Services S.A.** · enrollment: 400 (estimated)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** N-Acetyl-GED-0507-34-Levo
- **DRUG:** N-Acetyl-GED-0507-34-Levo corresponding vehicle

## Key facts

- **NCT ID:** NCT07384208
- **Lead sponsor:** PPM Services S.A.
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-11-19
- **Primary completion:** 2026-03
- **Final completion:** 2026-03
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07384208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07384208, "A Study to Assess Efficacy and Safety of N-Acetyl-GED-0507-34-LEVO Gel 5% in Patients With Acne Vulgaris (GEDACNE 2)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07384208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*